期刊文献+

药物洗脱支架内再狭窄的危险因素分析 被引量:1

Analysis of risk factors of in-stent restenosis after coronary implantation of drug-eluting stent
原文传递
导出
摘要 目的探讨冠状动脉药物洗脱支架内再狭窄的危险因素。方法对157例行冠状动脉药物洗脱支架植入术患者的临床资料进行回顾性分析,按照冠状动脉造影结果分为再狭窄组33例和无再狭窄组124例,采用单因素及Logistic多因素回归分析其临床及冠状动脉造影特征与药物洗脱支架内再狭窄的相关性。结果再狭窄组33例,糖尿病18例(54.5%),术后反复心绞痛26例(78.8%);无再狭窄组124例,糖尿病31例(25.0%),术后反复心绞痛72例(58.1%),组间差异有统计学意义(X^2=10.60,P〈0.01;)(2=4.77,P=0.03)。2组慢性完全闭塞分别为11例(19.3%)、12例(7.6%),分叉病变12例(21.1%)、16例(10.2%),弥漫病变15例(26.3%)、19例(12.1%),组间差异有统计学意义(x。值分别为5.92、4.34、6.32,P均〈0.05)。再狭窄组植入支架57枚,无再狭窄组植入157枚。logistic多因素分析显示糖尿病、术后反复心绞痛、慢性完全闭塞、分叉病变、弥漫病变和支架长度与支架内再狭窄相关(OR分别为3.52、2.59、3.05、3.14、3.08、0.93,95%C1分别为1.56~7.90,1.02~6.59,1.11~8.36,1.30~7.59。1.34~7.05,0.88—0.98,P均〈0.05)。结论冠状动脉药物洗脱支架植入术后,糖尿病史、术后反复发生心绞痛、慢性完全闭塞、分叉病变、弥漫病变及支架长度为支架内再狭窄的危险因素。 Objective To investigate the risk factors of in-stent restenosis (ISR) after coronary implantation of drug-eluting stent. Methods One hundred and fifty-seven patients including 118 males and 39 females,who underwent successful implantation of drug-eluting stem, were recruited in the study. The patients were divided into the restenosis group (33 patients) and non-restenosis group (124 patients) according to the angiographic results. The associations of ISR with clinical and coronary angiographic characteristics were analyzed using univiriate analysis and logistic regression. Results In the restenosis group,there were 18 cases of diabetes mellitus (54. 5% ),26 cases of frequency angina (78. 8% ),which were significantly higher than those of 31 cases of diabetes (25.0%) and 72 case of frequent angina (58. 1% ) in the non-restenosis group ( X^2 = 10. 60, P 〈 0. 01, X^2 = 4. 77, P = 0.03 for diabetes mellitus and frequent angina, respectively). Compared to non-restenosis group, the occurrence rates of chronic total occasion, bifurcatus lesions, diffuse lesions were significantly higher in the restenosis group ( 19. 3% vs 7. 6% X2 =5.92,21.1% vs 10. 2% X^2 =4. 34,26. 3% vs 12. 1% X^2 =6. 32,Ps 〈0. 05). Fifty-seven stents were implanted into the restenosis group,and one hundred and fifty-seven into the non-restenosis group. Logistic regression analysis showed that diabetes, frequent angina, chronic total occlusion lesions, bifurcatus lesions, diffuse lesions, stent length and diameter were significantly associated with restenosis ( OR value were 3.52,2. 59,3.05,3.14,3.08,0. 93,95% CI were 1.56 - 7.90, 1.02 - 6. 59,1.11 - 8. 36,1.30 - 7.59,1.34 - 7.05,0. 88 - 0. 98 respectively, Ps 〈 0. 05 ). Conclusion After implantation of drug-eluting stent, diabetes mellitus, chronic total occasion lesions, frequent angina, diffuse lesions,bifurcatus lesions and stent length and diameter are associated with follow-up restenosis.
出处 《中国综合临床》 2011年第2期136-139,共4页 Clinical Medicine of China
关键词 支架内再狭窄 药物洗脱支架 危险因素 慢性完全闭塞 In-stent restenosis Drug-eluting stem Risk factors Chronic total occasion
  • 相关文献

参考文献14

  • 1Alfonso F,Pérez-Vizcayno M J,Hernandez R,et al.A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis:results of the Restenosis Intrastent:Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting(RIBS-Ⅱ) trial[J].J Am Coll Cardiol,2006,47 (11):2152-2160.
  • 2Kastrati A,Mehilli J,von Beckerath N,et al.Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis:a randomized controlled trial[J].JAMA,2005,293(2):165-171.
  • 3贾东煜,王贵学.血管支架内再狭窄相关因素与机制的研究进展[J].中国组织工程研究与临床康复,2007,11(35):7061-7064. 被引量:24
  • 4Süselbeck T,Latsch A,Siri H,et al.Role of vessel size as a predictor for the occurrence of in-stent restenosis in patients with diabetes mellitus[J].Am J Cardiol,2001,88 (3):243-247.
  • 5Chu WW,Kuchulakanti PK,Torguson R,et al.Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention[J].Catheter Cardiovasc Interv,2006,67(4):595-599.
  • 6Stettler C,Allemann S,Egger M,et al.Efficacy of drug eluting stents in patients with and without diabetes mellitus:indirect comparison of controlled trials[J].Heart,2006,92 (5):650-657.
  • 7Machecourt J,Danchin N,Lablanche JM,et al. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients:the EVASTENT Matched-Cohort Registry[J].J Am Coll Cardiol,2007,50(6):501-508.
  • 8Singh M,Gersh BJ,McClelland RL,et al. Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes(PRESTO) trial[J].J Am Coll Cardiol,2005,45 (2):198-203.
  • 9Betge S,Krack A,Figulla HR,et al.Analysis of location and pattern of target vessel failure in chronic total occlusions after stent implantation and its potential for the efficient use of drug-eluting stents[J].J Interv Cardiol,2006,19(3):226-231.
  • 10曹蕊,黄雄,曹雪滨,张刚,崔英凯,毛继康.国产雷帕霉素药物洗脱支架的临床应用[J].中国循证心血管医学杂志,2009,1(2):88-90. 被引量:4

二级参考文献34

  • 1潘长江,唐家驹,王进,黄楠.血管支架内再狭窄的机理研究进展[J].中国介入影像与治疗学,2005,2(4):314-317. 被引量:17
  • 2CHEN Shao-liang,YE Fei,ZHANG Jun-jie,ZHU Zhong-sheng,LIN Song,SHAN Shou-jie,LIU Zhi-zhong,LIU Yan,DUAN Bao-xiang,GE Jun-bo.DK crush technique: modified treatment of bifurcation lesions in coronary artery[J].Chinese Medical Journal,2005(20):1746-1750. 被引量:35
  • 3Speidel CM,Eisenberg PR,Ruf W,et al.Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits.Circulation 1995;92(11):3323-3330
  • 4Eto K,Goto S,Shimazaki T,et al.Two distinct mechanisms are involved in stent thrombosis under flow conditions.Platelets 2001;12(4):228-235
  • 5Nakatani M,Takeyama Y,Shibata M,et al.Mechanisms of restenosis after coronary intervention:difference between plain old balloon angioplasty and stenting.Cardiovasc Pathol 2003;12(1):40-48
  • 6Inoue T,Kato T,Hikichi Y,et al.Stent-induced neutrophil activation is associated with an oxidative burst in the inflammatory process,leading to neointimal thickening.Thromb Haemost 2006;95(1):43-48
  • 7Inoue T,Komoda H,Kotooka N,et al.Increased circulating platelet-derived microparticles are associated with stent-induced vascular inflammation.Atherosclerosis 2007;[Epub ahead of print]
  • 8Sata M,Saiura A,Kunisato A,et al.Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.Nat Med 2002;8(4):403-409
  • 9Caplice NM,Bunch TJ,Stalboerger PG,et al.Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation.Proc Natl Acad Sci U S A 2003;100(8):4754-4759
  • 10Fang YI,Namiki H,Tsunoda E,et al.Marked increase in the histamine content of neointima after stent implantation of pig coronary artery and growth-promoting effects of histamine in cultured smooth muscle cells.Life Sci 2005;77(3):241-251

共引文献30

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部